Kosinska, A.D.; Festag, J.; Mück-Häusl, M.; Festag, M.M.; Asen, T.; Protzer, U.
Immunogenicity and Antiviral Response of Therapeutic Hepatitis B Vaccination in a Mouse Model of HBeAg-Negative, Persistent HBV Infection. Vaccines 2021, 9, 841.
https://doi.org/10.3390/vaccines9080841
AMA Style
Kosinska AD, Festag J, Mück-Häusl M, Festag MM, Asen T, Protzer U.
Immunogenicity and Antiviral Response of Therapeutic Hepatitis B Vaccination in a Mouse Model of HBeAg-Negative, Persistent HBV Infection. Vaccines. 2021; 9(8):841.
https://doi.org/10.3390/vaccines9080841
Chicago/Turabian Style
Kosinska, Anna D., Julia Festag, Martin Mück-Häusl, Marvin M. Festag, Theresa Asen, and Ulrike Protzer.
2021. "Immunogenicity and Antiviral Response of Therapeutic Hepatitis B Vaccination in a Mouse Model of HBeAg-Negative, Persistent HBV Infection" Vaccines 9, no. 8: 841.
https://doi.org/10.3390/vaccines9080841
APA Style
Kosinska, A. D., Festag, J., Mück-Häusl, M., Festag, M. M., Asen, T., & Protzer, U.
(2021). Immunogenicity and Antiviral Response of Therapeutic Hepatitis B Vaccination in a Mouse Model of HBeAg-Negative, Persistent HBV Infection. Vaccines, 9(8), 841.
https://doi.org/10.3390/vaccines9080841
